Microdermabrasion is a non-invasive cosmetic procedure that uses an exfoliation method to scrub off the topmost layer of dead skin cells and debris by using a hand-held microdermabrasion machine with vacuum suction and crystal exfoliation. It is widely used for anti-aging purposes such as reducing signs of acne, acne scarring, fine lines and wrinkles. It can also treat hyperpigmentation, treat sun damage, minimize pores, and improve skin tone and texture. The global microdermabrasion devices market is comprised of crystal microdermabrasion devices and diamond microdermabrasion devices. Crystal microdermabrasion devices use aluminum oxide or sodium chloride crystals to slough off dead skin, while diamond microdermabrasion devices use diamond-tipped brushes to remove the surface layers of skin. The global microdermabrasion devices market is estimated to be valued at US$ 517.61 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The microdermabrasion devices market is expected to be flourished by rising demand for non-invasive cosmetic procedures. With increasing preference towards aesthetic appearance, consumers are opting for minimally invasive procedures that offer anti-aging benefits and skin rejuvenation. People are willingly undergoing cosmetic treatments to reduce signs of aging such as wrinkles and skin blemishes without any major surgery or downtime. Microdermabrasion is considered as a safe, less painful and effective procedure to achieve youthful and healthy skin. In addition, growing skincare and beauty consciousness among individuals has led to surge in demand for anti-aging treatments worldwide. According to American Society for Aesthetic Plastic Surgery (ASAPS), nonsurgical cosmetic procedures grew substantially in 2018 and 2019. The number of anti-aging treatments such as botulinum toxins and soft tissue fillers increased by 7%. Hence, rising preference for non-invasive aesthetic treatments is expected to drive growth of microdermabrasion devices market over the forecast period.
The global microdermabrasion devices market can be segmented based on type, application and end-use. Based on type, the crystal microdermabrasion segment holds the highest market share of around 60%. Crystal microdermabrasion is dominating the market as it is the most effective method for mild exfoliation of the outermost layer of dead skin cells. Based on application, the acne & scars segment accounts for over 35% of market share. Microdermabrasion is highly effective in reducing acne scars and marks left behind by acne lesions. Based on end-use, the hospitals & dermatology clinics segment is the dominant segment owing to availability of advanced facilities and presence of skilled professionals.
Political: Government regulations related to medical aesthetics procedures are becoming more stringent to ensure safety. This is positively impacting market growth.
Economic: Rising disposable incomes coupled with growing medical tourism industry in developing nations is fueling market expansion. High device costs could however restrain growth to some extent.
Social: Surging desire to maintain youthful appearance and growing social acceptance of cosmetic procedures are driving market demand. Increased awareness about availability of minimally invasive treatments augurs well for market growth.
Technological: Advancements in crystal and diamond tip technology have made microdermabrasion more efficient and comfortable for patients. Development of portable handheld devices has further boosted popularity.
The Global Microdermabrasion Devices Market Size is expected to witness high growth at a CAGR of 7.4% during the forecast period of 2023 to 2030.
Regional analysis: North America currently accounts for the largest share of around 40% owing to early availability of advanced technologies and growing medical aesthetics industry in the region.
Key players operating in the microdermabrasion devices market are Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals.